173 related articles for article (PubMed ID: 21430600)
1. Reduced pericellular sensitivity to IGF-I in fibroblasts from girls with Turner syndrome: a mechanism to impair clinical responses to GH.
Westwood M; Tajbakhsh SH; Siddals KW; Whatmore AJ; Clayton PE
Pediatr Res; 2011 Jul; 70(1):25-30. PubMed ID: 21430600
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factors (IGF-I and IGF-II) and IGF-binding protein-3 production by fibroblasts of patients with Turner's syndrome in culture.
Barreca A; Larizza D; Damonte G; Arvigo M; Ponzani P; Cesarone A; Lo Curto F; Severi F; Giordano G; Minuto F
J Clin Endocrinol Metab; 1997 Apr; 82(4):1041-6. PubMed ID: 9100570
[TBL] [Abstract][Full Text] [Related]
3. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
Bannink EM; van Doorn J; Stijnen T; Drop SL; de Muinck Keizer-Schrama SM
Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949
[TBL] [Abstract][Full Text] [Related]
4. Plasma growth hormone-binding protein activity, insulin-like growth factor I, and its binding protein levels in patients with Turner's syndrome: effect of short- and long-term recombinant human growth hormone administration.
Saggese G; Federico G; Cinquanta L
Pediatr Res; 1995 Jan; 37(1):106-11. PubMed ID: 7535419
[TBL] [Abstract][Full Text] [Related]
5. The GH-IGF-IGFBP axis is changed in Turner syndrome: partial normalization by HRT.
Gravholt CH; Chen JW; Oxvig C; Overgaard MT; Christiansen JS; Frystyk J; Flyvbjerg A
Growth Horm IGF Res; 2006; 16(5-6):332-9. PubMed ID: 17067837
[TBL] [Abstract][Full Text] [Related]
6. Ovarian expression of insulin-like growth factor-I (IGF-I), IGF binding proteins, and growth hormone (GH) receptor in heifers actively immunized against GH-releasing factors.
Cohick WS; Armstrong JD; Whitacre MD; Lucy MC; Harvey RW; Campbell RM
Endocrinology; 1996 May; 137(5):1670-7. PubMed ID: 8612500
[TBL] [Abstract][Full Text] [Related]
7. Differential regulation of insulin-like growth factor-(IGF) I and IGF-binding protein (IGFBP) secretion by human peripheral blood mononuclear cells.
Auernhammer CJ; Fottner C; Engelhardt D; Bidlingmaier M; Strasburger CJ; Weber MM
Horm Res; 2002; 57(1-2):15-21. PubMed ID: 12006714
[TBL] [Abstract][Full Text] [Related]
8. Skin fibroblasts of children with idiopathic short stature show an increased mitogenic response to IGF-I and secrete more IGFBP-3.
Kamp GA; Ouwens DM; Hoogerbrugge CM; Zwinderman AH; Maassen JA; Wit JM
Clin Endocrinol (Oxf); 2002 Apr; 56(4):439-47. PubMed ID: 11966736
[TBL] [Abstract][Full Text] [Related]
9. IGF-I differentially regulates IGF-binding protein expression in primary mammary fibroblasts and epithelial cells.
Fleming JM; Leibowitz BJ; Kerr DE; Cohick WS
J Endocrinol; 2005 Jul; 186(1):165-78. PubMed ID: 16002546
[TBL] [Abstract][Full Text] [Related]
10. Short-term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity: a randomized, double-blind, placebo-controlled, crossover study.
Gravholt CH; Naeraa RW; Brixen K; Kastrup KW; Mosekilde L; Jørgensen JO; Christiansen JS
Pediatrics; 2002 Nov; 110(5):889-96. PubMed ID: 12415026
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone (GH) treatment reduces peripheral thyroid hormone action in girls with Turner syndrome.
Susperreguy S; Miras MB; Montesinos MM; Mascanfroni ID; Muñoz L; Sobrero G; Silvano L; Masini-Repiso AM; Coleoni AH; Targovnik HM; Pellizas CG
Clin Endocrinol (Oxf); 2007 Oct; 67(4):629-36. PubMed ID: 17666093
[TBL] [Abstract][Full Text] [Related]
12. Insulin, insulin-like growth factor-binding protein-1, and sex hormone-binding globulin in patients with Turner's syndrome: course over age in untreated patients and effect of therapy with growth hormone alone and in combination with oxandrolone.
Haeusler G; Schmitt K; Blümel P; Plöchl E; Waldhör T; Frisch H
J Clin Endocrinol Metab; 1996 Feb; 81(2):536-41. PubMed ID: 8636264
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone bioactivity in girls with Turner's syndrome: correlation with insulin-like growth factor I.
Foster CM; Borondy M; Markovs ME; Hopwood NJ; Kletter GB; Beitins IZ
Pediatr Res; 1994 Feb; 35(2):218-22. PubMed ID: 7513079
[TBL] [Abstract][Full Text] [Related]
14. Serum growth hormone (GH)-binding protein and insulin-like growth factor-I levels in Turner's syndrome before and during treatment with recombinant human GH and ethinyl estradiol.
Massa G; Bouillon R; Vanderschueren-Lodeweyckx M
J Clin Endocrinol Metab; 1992 Nov; 75(5):1298-302. PubMed ID: 1430092
[TBL] [Abstract][Full Text] [Related]
15. Yearly stepwise increments of the growth hormone dose results in a better growth response after four years in girls with Turner syndrome. Dutch Working Group on Growth Hormone.
van Teunenbroek A; de Muinck Keizer-Schrama SM; Stijnen T; Jansen M; Otten BJ; Delemarre-van de Waal HA; Vulsma T; Wit JM; Rouwé CW; Reeser HM; Gosen JJ; Rongen-Westerlaken C; Drop SL
J Clin Endocrinol Metab; 1996 Nov; 81(11):4013-21. PubMed ID: 8923853
[TBL] [Abstract][Full Text] [Related]
16. Genital skin fibroblasts (GF) of patients with androgen insensitivity syndrome express higher insulin-like growth factor binding protein (IGFBP)-2, -3 and -5 than GF of normally virilized males.
Diesing D; Elmlinger MW; Schuett BS; Weidemann W; Romalo G; Schweikert HU; Spindler KD; Ranke MB
Horm Res; 2003; 60(2):73-8. PubMed ID: 12876417
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of thyroid hormone action on the insulin-like growth factor system: all thyroid hormone effects are not growth hormone mediated.
Näntö-Salonen K; Muller HL; Hoffman AR; Vu TH; Rosenfeld RG
Endocrinology; 1993 Feb; 132(2):781-8. PubMed ID: 7678799
[TBL] [Abstract][Full Text] [Related]
18. Effects of GH and/or sex steroids on circulating IGF-I and IGFBPs in healthy, aged women and men.
Münzer T; Rosen CJ; Harman SM; Pabst KM; St Clair C; Sorkin JD; Blackman MR
Am J Physiol Endocrinol Metab; 2006 May; 290(5):E1006-13. PubMed ID: 16390864
[TBL] [Abstract][Full Text] [Related]
19. Binding of insulin-like growth factor (IGF) I or II to IGF-binding protein-2 enables it to bind to heparin and extracellular matrix.
Arai T; Busby W; Clemmons DR
Endocrinology; 1996 Nov; 137(11):4571-5. PubMed ID: 8895319
[TBL] [Abstract][Full Text] [Related]
20. Growth response and levels of growth factors after two years growth hormone treatment are similar for a once and twice daily injection regimen in girls with Turner syndrome. (Dutch Working Group on Growth Hormone).
van Teunenbroek A; de Muinck Keizer-Schrama S; Stijnen T; Waelkens J; Wit JM; Vulsma T; Gerver WJ; Reeser H; Delemarre-van de Waal H; Jansen M; Drop S
Clin Endocrinol (Oxf); 1997 Apr; 46(4):451-9. PubMed ID: 9196608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
